Mental and Physical Health, Psychosocial Maturity, and Desistance in Young Adulthood

por Ward, Jeffrey T., Link, Nathan W., Forney, Megan
Publicado 2023

Preparation and Use of HIV-1 Infected Primary CD4+ T-Cells as Target Cells in Natural Killer Cell Cytotoxic Assays

por Davis, Zachary B., Ward, Jeffrey P., Barker, Edward
Publicado 2011

The Influence of Viral Infections on Iron Homeostasis and the Potential for Lactoferrin as a Therapeutic in the Age of the SARS-CoV-2 Pandemic

por Ward, Jeffrey L., Torres-Gonzalez, Moises, Ammons, Mary Cloud B.
Publicado 2022

A powered prosthetic ankle joint for walking and running

por Grimmer, Martin, Holgate, Matthew, Holgate, Robert, Boehler, Alexander, Ward, Jeffrey, Hollander, Kevin, Sugar, Thomas, Seyfarth, André
Publicado 2016

HIV-1 Vpr Triggers Natural Killer Cell–Mediated Lysis of Infected Cells through Activation of the ATR-Mediated DNA Damage Response

por Ward, Jeffrey, Davis, Zachary, DeHart, Jason, Zimmerman, Erik, Bosque, Alberto, Brunetta, Enrico, Mavilio, Domenico, Planelles, Vicente, Barker, Edward
Publicado 2009

Lysis of Endogenously Infected CD4+ T Cell Blasts by rIL-2 Activated Autologous Natural Killer Cells from HIV-Infected Viremic Individuals

por Fogli, Manuela, Mavilio, Domenico, Brunetta, Enrico, Varchetta, Stefania, Ata, Khaled, Roby, Gregg, Kovacs, Colin, Follmann, Dean, Pende, Daniela, Ward, Jeffrey, Barker, Edward, Marcenaro, Emanuela, Moretta, Alessandro, Fauci, Anthony S.
Publicado 2008

Exploring the Feasibility of Utilizing Limited Gene Panel Circulating Tumor DNA Clearance as a Biomarker in Patients With Locally Advanced Non-Small Cell Lung Cancer

por Knapp, Brendan, Mezquita, Laura, Devarakonda, Siddhartha, Aldea, Mihaela, Waqar, Saiama N., Pepin, Kym, Ward, Jeffrey P., Botticella, Angela, Howarth, Karen, Knape, Charlene, Morris, Clive, Govindan, Ramaswamy, Besse, Benjamin, Morgensztern, Daniel
Publicado 2022

BHLHE40 Regulates the T-Cell Effector Function Required for Tumor Microenvironment Remodeling and Immune Checkpoint Therapy Efficacy

por Salmon, Avery J., Shavkunov, Alexander S., Miao, Qi, Jarjour, Nicholas N., Keshari, Sunita, Esaulova, Ekaterina, Williams, Charmelle D., Ward, Jeffrey P., Highsmith, Anna M., Pineda, Josué E., Taneja, Reshma, Chen, Ken, Edelson, Brian T., Gubin, Matthew M.
Publicado 2022

cDC1 prime and are licensed by CD4 T cells to induce anti-tumour immunity

por Ferris, Stephen T., Durai, Vivek, Wu, Renee, Theisen, Derek J., Ward, Jeffrey P., Bern, Michael D., Davidson, Jesse T., Bagadia, Prachi, Liu, Tiantian, Briseño, Carlos G., Li, Lijin, Gillanders, William E., Wu, Gregory F., Yokoyama, Wayne M., Murphy, Theresa L., Schreiber, Robert D., Murphy, Kenneth M.
Publicado 2020

MHC-II neoantigens shape tumor immunity and response to immunotherapy

por Alspach, Elise, Lussier, Danielle M., Miceli, Alexander P., Kizhvatov, Ilya, DuPage, Michel, Luoma, Adrienne M., Meng, Wei, Lichti, Cheryl F., Esaulova, Ekaterina, Vomund, Anthony N., Runci, Daniele, Ward, Jeffrey P., Gubin, Matthew M., Medrano, Ruan F.V., Arthur, Cora D., White, J. Michael, Sheehan, Kathleen C.F., Chen, Alex, Wucherpfennig, Kai W., Jacks, Tyler, Unanue, Emil R., Artyomov, Maxim N., Schreiber, Robert D.
Publicado 2019

Checkpoint Blockade Cancer Immunotherapy Targets Tumour-Specific Mutant Antigens

por Gubin, Matthew M., Zhang, Xiuli, Schuster, Heiko, Caron, Etienne, Ward, Jeffrey P., Noguchi, Takuro, Ivanova, Yulia, Hundal, Jasreet, Arthur, Cora D., Krebber, Willem-Jan, Mulder, Gwenn E., Toebes, Mireille, Vesely, Matthew D., Lam, Samuel S.K., Korman, Alan J., Allison, James P., Freeman, Gordon J., Sharpe, Arlene H., Pearce, Erika L., Schumacher, Ton N., Aebersold, Ruedi, Rammensee, Hans-Georg, Melief, Cornelis J. M., Mardis, Elaine R., Gillanders, William E., Artyomov, Maxim N., Schreiber, Robert D.
Publicado 2014